![Scott Donlea](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Scott Donlea
Private-Equity-Analyst bei Denargo Capital LLC
Aktive Positionen von Scott Donlea
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Denargo Capital LLC
![]() Denargo Capital LLC Investment ManagersFinance Denargo Capital LLC (Denargo Capital) is a private equity firm founded in 2003 by Tom D. Heule, Pål Berg and Paul A. Lyons. The firm is headquartered in Greenwood Village, Colorado. | Private-Equity-Analyst | 01.08.2008 | - |
Karriereverlauf von Scott Donlea
Ehemalige bekannte Positionen von Scott Donlea
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
RCC
![]() RCC Miscellaneous Commercial ServicesCommercial Services RCC is a Norwegian company that focuses on kidney cancer, which is one of the top 10 most commonly diagnosed forms of cancer among both men and women in the United States. Clear cell RCC is the most common type of kidney cancer in adults, while NCCRCC represents about 20-25%% of RCC cases, with fewer treatment options available and poorer outcomes compared with clear cell RCC. The company highlights the importance of early detection, as the five-year survival rate is high for patients with early-stage RCC. However, for patients with advanced or late-stage metastatic RCC, the five-year survival rate is only 14%%. RCC was acquired by AGR Ability Group on January 18, 2005 for $22.35 million. | Corporate Officer/Principal | - | - |
Statistik
International
Norwegen | 2 |
Vereinigte Staaten | 2 |
Operativ
Private Equity Analyst | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Commercial Services | 2 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
RCC
![]() RCC Miscellaneous Commercial ServicesCommercial Services RCC is a Norwegian company that focuses on kidney cancer, which is one of the top 10 most commonly diagnosed forms of cancer among both men and women in the United States. Clear cell RCC is the most common type of kidney cancer in adults, while NCCRCC represents about 20-25%% of RCC cases, with fewer treatment options available and poorer outcomes compared with clear cell RCC. The company highlights the importance of early detection, as the five-year survival rate is high for patients with early-stage RCC. However, for patients with advanced or late-stage metastatic RCC, the five-year survival rate is only 14%%. RCC was acquired by AGR Ability Group on January 18, 2005 for $22.35 million. | Commercial Services |
Denargo Capital LLC
![]() Denargo Capital LLC Investment ManagersFinance Denargo Capital LLC (Denargo Capital) is a private equity firm founded in 2003 by Tom D. Heule, Pål Berg and Paul A. Lyons. The firm is headquartered in Greenwood Village, Colorado. | Finance |
- Börse
- Insiders
- Scott Donlea
- Erfahrung